Thrombosis Update/X
Jun 15, 2025, 09:32
Silent Threat: Underrated Risk of Thrombosis in IBD Outpatients Revealed by New Data – Thrombosis Update
Thrombosis Update has presented new developments in its recent issue on X:
“New study in ThrombUpdate reveals a significant, often underestimated, risk of blood clots in IBD out-patients. They auhtors found 7.6% experienced a thromboembolic event in IBD patients.”
Title: Venous and arterial thromboembolism in out-patients with inflammatory bowel disease: a single center study
Autors: Antonella Tufano, Anna Testa, Marta Patturelli, Antonio Rispo, Vincenzo Fotticchia, Paola Rufolo, Federica Strano, Alessia Dalila Guarino, Antonietta Vitale, Olga Maria Nardone, Mario Ferrante, Rossella Caso, Fabiana Castiglione.
A new study published in Thrombosis Update highlights a significant and often underrecognized risk of thromboembolic events among outpatients with inflammatory bowel disease (IBD).
For more detailed insights, visit Hemostasis Today.
Alessia Dalila Guarino
American Society of Hematology
American Thrombosis and Hemostasis Network
Anna Testa
Antonella Tufano
Antonietta Vitale
Antonio Rispo
Clinical Implications
Fabiana Castiglione
Federica Strano
Hematology
Hemostasis
Hemostasis Today
Inflammatory Bowel Disease (IBD)
International Society on Thrombosis and Haemostasis (ISTH)
Mario Ferrante
Marta Patturelli
New Data-Thrombosis Update
Olga Maria Nardone
Outpatients
Paola Rufolo
Real-world Data
Risk Stratification
Rossella Caso
Thromboembolic Events
thrombosis
Thrombosis Update
TruJournal
Underrated Risk of Thrombosis
Vincenzo Fotticchia
-
Aug 15, 2025, 23:36Irene M Lang's Editorial on Getting Risk Assessment Right in Acute Pulmonary Embolism
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 14, 2025, 10:58Thomas Reiser: Why October 13 Marks World Thrombosis Day?
-
Aug 15, 2025, 23:35SEC61B Mediated Platelet Hyperactivity in People with Diabetes
-
Aug 15, 2025, 23:32Fibrinogen Concentrate Safely Replaces Cryoprecipitate in Neonatal Cardiac Surgery
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 15, 2025, 23:33Kacper Odziomek Excels in 2 Pharmacology Courses from Harvard Medical School
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
Aug 15, 2025, 23:35
Aug 15, 2025, 23:33
Aug 15, 2025, 14:23
Aug 14, 2025, 23:47
Aug 14, 2025, 23:47
Aug 14, 2025, 17:36